ChemicalBook > Product Catalog >Biochemical Engineering >Biochemical Reagents >Agonist Inhibitors >E-7449

E-7449

E-7449 Suppliers list
Company Name: Deyang Sino Biotech. Co., LTD  Gold
Tel: +86-19182167371
Email: service@synlord.com
Company Name: WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.  
Tel: 17702719238
Email: sales@sun-shinechem.com
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Company Name: LETOPHARM LIMITED  
Tel: +86-21-5821 5861
Email: sales@letopharm.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
E-7449 Basic information
Product Name:E-7449
Synonyms:E-7449;8-(1,3-dihydro-isoindol-2-ylmethyl)-2,9-dihydro-1,2,7,9-tetraaza-phenalen-3-one;E7449;E 7449;3H-Pyridazino[3,4,5-de]quinazolin-3-one, 8-[(1,3-dihydro-2H-isoindol-2-yl)methyl]-1,2-dihydro-;UNII-9X5A2QIA7C;Stenoparib (E7449);E7449,PARP,Inhibitor,inhibit,E 7449,E-7449,poly ADP ribose polymerase;Stenoparib, E7449, 2X-121
CAS:1140964-99-3
MF:C18H15N5O
MW:317.34
EINECS:
Product Categories:
Mol File:1140964-99-3.mol
E-7449 Structure
E-7449 Chemical Properties
density 1.53±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO:0.2(Max Conc. mg/mL);0.63(Max Conc. mM)
form A crystalline solid
pka9.51±0.20(Predicted)
color Light yellow to yellow
InChIInChI=1S/C18H15N5O/c24-18-13-6-3-7-14-16(13)17(21-22-18)20-15(19-14)10-23-8-11-4-1-2-5-12(11)9-23/h1-7H,8-10H2,(H,22,24)(H,19,20,21)
InChIKeyJLFSBHQQXIAQEC-UHFFFAOYSA-N
SMILESN1=C2C3C(C(=O)NNC=3N=C1CN1CC3=C(C1)C=CC=C3)=CC=C2
Safety Information
MSDS Information
E-7449 Usage And Synthesis
UsesE 7449 is a dual inhibitor of PARP1/2 and tankyrase1/2 exhibits anti-tumor activity in BRCA-deficient in vivo models. PARP1/2 and tankyrase1/2 are involved with DNA damage and canonical Wnt/β-catenin signaling, respectively.
in vivo

Stenoparib moderately inhibits the growth of tumors at 100 mg/kg, and significantly ehhances the inhibition via 10, 30 and 100 mg/kg oral dosing in combination with temozolomide (TMZ) in the mouse melanoma B16-F10 isograft model. Stenoparib (30 or 100 mg/kg, p.o.) inhibits PARP, shows anti-tumor activity, and is well-tolerated without any obvious body weight loss or deaths in a BRCA mutant xenograft model. Stenoparib (30, 100 or 300 mg/kg, p.o.) suppresses re-growth of hair in a dose dependent manner, and blocks Wnt signaling in C57BL/6 mice. Stenoparib (100 mg/kg, p.o.) combined with MEK inhibitor exhibits antitumor activity in a Wnt1 subcutaneous model (mammary tumors initially isolated from Wnt1 (int-1) transgenic mice)[1].

IC 50PARP2: 1 nM (IC50); PARP1: 2 nM (IC50); TNKS1: 50 nM (IC50); TNKS2: 50 nM (IC50)
E-7449 Preparation Products And Raw materials
Tag:E-7449(1140964-99-3) Related Product Information
E-7449 3-Aminobenzamide JW55 WIKI4 G007-LK ABT-888